The Latest Breaking News from ELV

Although Elevance Health has underperformed the broader market over the past 52 weeks, Wall Street analysts remain bullish about the stock's prospects.

Elevance Health will release its fourth-quarter earnings later this month, and analysts anticipate a double-digit profit dip.

During economic uncertainty, dividend growth stocks are a smart choice for stable passive income, inflation protection, and potential for increasing dividends, offering security in a volatile market. Therefore, investors might consider buying dividend growth stocks like Elevance Health (ELV), Enterprise Products Partners (EPD), and HP (HPQ), each with over 10…

With rising medical costs and an expanding aging population, the health insurance sector is set to witness significant growth. Hence, investors looking to capitalize on this trend could consider stable health insurance stocks Elevance Health (ELV), Cigna Group (CI), and Centene (CNC). Read on….

Elevance Health has outperformed the Nasdaq Composite over the past year, and Wall Street analysts remain optimistic about the stock’s prospects.

UnitedHealth has outperformed the Nasdaq recently, and analysts are highly optimistic about the stock’s prospects.

Elevance Health has underperformed the broader market this year, but Wall Street analysts are optimistic about the stock’s prospects.

As the aging population drives significant opportunities for companies involved in pharmaceuticals, medical devices, and health care services, let’s not miss out on investing in quality stocks like Thermo Fisher Scientific (TMO), Medtronic (MDT), and Korn Ferry (KFY), which are poised to meet the needs of an aging demographic. Learn…

A very private family office finds itself in the middle of a nasty spat with a trio of money managers.